Global Active Pharmaceutical Ingredients CDMO Market Research Report 2024(Status and Outlook)
Report Overview
contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
This report provides a deep insight into the global Active Pharmaceutical Ingredients CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredients CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredients CDMO market in any manner.
Global Active Pharmaceutical Ingredients CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cambrex
Recipharm
Thermo Fisher Pantheon
Corden Pharma
Samsung Biologics
Lonza
Catalent
Siegfried
Piramal Pharma Solutions
Boehringer Ingelheim
Market Segmentation (by Type)
Traditional Active Pharmaceutical Ingredient (Traditional API)
Highly Potent Active Pharmaceutical Ingredient (HP-API)
Antibody Drug Conjugate (ADC)
Others
Market Segmentation (by Application)
Oncology
Hormonal
Glaucoma
Cardiovascular
Diabetes
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Active Pharmaceutical Ingredients CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
contract manufacturing organization (CMO), sometimes called a contract development and manufacturing organization (CDMO), is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.
This report provides a deep insight into the global Active Pharmaceutical Ingredients CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Active Pharmaceutical Ingredients CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Active Pharmaceutical Ingredients CDMO market in any manner.
Global Active Pharmaceutical Ingredients CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Cambrex
Recipharm
Thermo Fisher Pantheon
Corden Pharma
Samsung Biologics
Lonza
Catalent
Siegfried
Piramal Pharma Solutions
Boehringer Ingelheim
Market Segmentation (by Type)
Traditional Active Pharmaceutical Ingredient (Traditional API)
Highly Potent Active Pharmaceutical Ingredient (HP-API)
Antibody Drug Conjugate (ADC)
Others
Market Segmentation (by Application)
Oncology
Hormonal
Glaucoma
Cardiovascular
Diabetes
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Active Pharmaceutical Ingredients CDMO Market
- Overview of the regional outlook of the Active Pharmaceutical Ingredients CDMO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Active Pharmaceutical Ingredients CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Active Pharmaceutical Ingredients CDMO
1.2 Key Market Segments
1.2.1 Active Pharmaceutical Ingredients CDMO Segment by Type
1.2.2 Active Pharmaceutical Ingredients CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Active Pharmaceutical Ingredients CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Active Pharmaceutical Ingredients CDMO Sales by Manufacturers (2019-2024)
3.2 Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Active Pharmaceutical Ingredients CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Active Pharmaceutical Ingredients CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Active Pharmaceutical Ingredients CDMO Sales Sites, Area Served, Product Type
3.6 Active Pharmaceutical Ingredients CDMO Market Competitive Situation and Trends
3.6.1 Active Pharmaceutical Ingredients CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredients CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO INDUSTRY CHAIN ANALYSIS
4.1 Active Pharmaceutical Ingredients CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2019-2024)
6.3 Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Active Pharmaceutical Ingredients CDMO Price by Type (2019-2024)
7 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Active Pharmaceutical Ingredients CDMO Market Sales by Application (2019-2024)
7.3 Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Active Pharmaceutical Ingredients CDMO Sales Growth Rate by Application (2019-2024)
8 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET SEGMENTATION BY REGION
8.1 Global Active Pharmaceutical Ingredients CDMO Sales by Region
8.1.1 Global Active Pharmaceutical Ingredients CDMO Sales by Region
8.1.2 Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Active Pharmaceutical Ingredients CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Active Pharmaceutical Ingredients CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Active Pharmaceutical Ingredients CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Active Pharmaceutical Ingredients CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cambrex
9.1.1 Cambrex Active Pharmaceutical Ingredients CDMO Basic Information
9.1.2 Cambrex Active Pharmaceutical Ingredients CDMO Product Overview
9.1.3 Cambrex Active Pharmaceutical Ingredients CDMO Product Market Performance
9.1.4 Cambrex Business Overview
9.1.5 Cambrex Active Pharmaceutical Ingredients CDMO SWOT Analysis
9.1.6 Cambrex Recent Developments
9.2 Recipharm
9.2.1 Recipharm Active Pharmaceutical Ingredients CDMO Basic Information
9.2.2 Recipharm Active Pharmaceutical Ingredients CDMO Product Overview
9.2.3 Recipharm Active Pharmaceutical Ingredients CDMO Product Market Performance
9.2.4 Recipharm Business Overview
9.2.5 Recipharm Active Pharmaceutical Ingredients CDMO SWOT Analysis
9.2.6 Recipharm Recent Developments
9.3 Thermo Fisher Pantheon
9.3.1 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Basic Information
9.3.2 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Overview
9.3.3 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Market Performance
9.3.4 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO SWOT Analysis
9.3.5 Thermo Fisher Pantheon Business Overview
9.3.6 Thermo Fisher Pantheon Recent Developments
9.4 Corden Pharma
9.4.1 Corden Pharma Active Pharmaceutical Ingredients CDMO Basic Information
9.4.2 Corden Pharma Active Pharmaceutical Ingredients CDMO Product Overview
9.4.3 Corden Pharma Active Pharmaceutical Ingredients CDMO Product Market Performance
9.4.4 Corden Pharma Business Overview
9.4.5 Corden Pharma Recent Developments
9.5 Samsung Biologics
9.5.1 Samsung Biologics Active Pharmaceutical Ingredients CDMO Basic Information
9.5.2 Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Overview
9.5.3 Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Market Performance
9.5.4 Samsung Biologics Business Overview
9.5.5 Samsung Biologics Recent Developments
9.6 Lonza
9.6.1 Lonza Active Pharmaceutical Ingredients CDMO Basic Information
9.6.2 Lonza Active Pharmaceutical Ingredients CDMO Product Overview
9.6.3 Lonza Active Pharmaceutical Ingredients CDMO Product Market Performance
9.6.4 Lonza Business Overview
9.6.5 Lonza Recent Developments
9.7 Catalent
9.7.1 Catalent Active Pharmaceutical Ingredients CDMO Basic Information
9.7.2 Catalent Active Pharmaceutical Ingredients CDMO Product Overview
9.7.3 Catalent Active Pharmaceutical Ingredients CDMO Product Market Performance
9.7.4 Catalent Business Overview
9.7.5 Catalent Recent Developments
9.8 Siegfried
9.8.1 Siegfried Active Pharmaceutical Ingredients CDMO Basic Information
9.8.2 Siegfried Active Pharmaceutical Ingredients CDMO Product Overview
9.8.3 Siegfried Active Pharmaceutical Ingredients CDMO Product Market Performance
9.8.4 Siegfried Business Overview
9.8.5 Siegfried Recent Developments
9.9 Piramal Pharma Solutions
9.9.1 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Basic Information
9.9.2 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Overview
9.9.3 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Market Performance
9.9.4 Piramal Pharma Solutions Business Overview
9.9.5 Piramal Pharma Solutions Recent Developments
9.10 Boehringer Ingelheim
9.10.1 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Basic Information
9.10.2 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Overview
9.10.3 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Market Performance
9.10.4 Boehringer Ingelheim Business Overview
9.10.5 Boehringer Ingelheim Recent Developments
10 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET FORECAST BY REGION
10.1 Global Active Pharmaceutical Ingredients CDMO Market Size Forecast
10.2 Global Active Pharmaceutical Ingredients CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Active Pharmaceutical Ingredients CDMO Market Size Forecast by Region
10.2.4 South America Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Active Pharmaceutical Ingredients CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Active Pharmaceutical Ingredients CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Active Pharmaceutical Ingredients CDMO by Type (2025-2030)
11.1.2 Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Active Pharmaceutical Ingredients CDMO by Type (2025-2030)
11.2 Global Active Pharmaceutical Ingredients CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Active Pharmaceutical Ingredients CDMO Sales (K Units) Forecast by Application
11.2.2 Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Active Pharmaceutical Ingredients CDMO
1.2 Key Market Segments
1.2.1 Active Pharmaceutical Ingredients CDMO Segment by Type
1.2.2 Active Pharmaceutical Ingredients CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Active Pharmaceutical Ingredients CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Active Pharmaceutical Ingredients CDMO Sales by Manufacturers (2019-2024)
3.2 Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Active Pharmaceutical Ingredients CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Active Pharmaceutical Ingredients CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Active Pharmaceutical Ingredients CDMO Sales Sites, Area Served, Product Type
3.6 Active Pharmaceutical Ingredients CDMO Market Competitive Situation and Trends
3.6.1 Active Pharmaceutical Ingredients CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Active Pharmaceutical Ingredients CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO INDUSTRY CHAIN ANALYSIS
4.1 Active Pharmaceutical Ingredients CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2019-2024)
6.3 Global Active Pharmaceutical Ingredients CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Active Pharmaceutical Ingredients CDMO Price by Type (2019-2024)
7 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Active Pharmaceutical Ingredients CDMO Market Sales by Application (2019-2024)
7.3 Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Active Pharmaceutical Ingredients CDMO Sales Growth Rate by Application (2019-2024)
8 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET SEGMENTATION BY REGION
8.1 Global Active Pharmaceutical Ingredients CDMO Sales by Region
8.1.1 Global Active Pharmaceutical Ingredients CDMO Sales by Region
8.1.2 Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Active Pharmaceutical Ingredients CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Active Pharmaceutical Ingredients CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Active Pharmaceutical Ingredients CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Active Pharmaceutical Ingredients CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Cambrex
9.1.1 Cambrex Active Pharmaceutical Ingredients CDMO Basic Information
9.1.2 Cambrex Active Pharmaceutical Ingredients CDMO Product Overview
9.1.3 Cambrex Active Pharmaceutical Ingredients CDMO Product Market Performance
9.1.4 Cambrex Business Overview
9.1.5 Cambrex Active Pharmaceutical Ingredients CDMO SWOT Analysis
9.1.6 Cambrex Recent Developments
9.2 Recipharm
9.2.1 Recipharm Active Pharmaceutical Ingredients CDMO Basic Information
9.2.2 Recipharm Active Pharmaceutical Ingredients CDMO Product Overview
9.2.3 Recipharm Active Pharmaceutical Ingredients CDMO Product Market Performance
9.2.4 Recipharm Business Overview
9.2.5 Recipharm Active Pharmaceutical Ingredients CDMO SWOT Analysis
9.2.6 Recipharm Recent Developments
9.3 Thermo Fisher Pantheon
9.3.1 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Basic Information
9.3.2 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Overview
9.3.3 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Market Performance
9.3.4 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO SWOT Analysis
9.3.5 Thermo Fisher Pantheon Business Overview
9.3.6 Thermo Fisher Pantheon Recent Developments
9.4 Corden Pharma
9.4.1 Corden Pharma Active Pharmaceutical Ingredients CDMO Basic Information
9.4.2 Corden Pharma Active Pharmaceutical Ingredients CDMO Product Overview
9.4.3 Corden Pharma Active Pharmaceutical Ingredients CDMO Product Market Performance
9.4.4 Corden Pharma Business Overview
9.4.5 Corden Pharma Recent Developments
9.5 Samsung Biologics
9.5.1 Samsung Biologics Active Pharmaceutical Ingredients CDMO Basic Information
9.5.2 Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Overview
9.5.3 Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Market Performance
9.5.4 Samsung Biologics Business Overview
9.5.5 Samsung Biologics Recent Developments
9.6 Lonza
9.6.1 Lonza Active Pharmaceutical Ingredients CDMO Basic Information
9.6.2 Lonza Active Pharmaceutical Ingredients CDMO Product Overview
9.6.3 Lonza Active Pharmaceutical Ingredients CDMO Product Market Performance
9.6.4 Lonza Business Overview
9.6.5 Lonza Recent Developments
9.7 Catalent
9.7.1 Catalent Active Pharmaceutical Ingredients CDMO Basic Information
9.7.2 Catalent Active Pharmaceutical Ingredients CDMO Product Overview
9.7.3 Catalent Active Pharmaceutical Ingredients CDMO Product Market Performance
9.7.4 Catalent Business Overview
9.7.5 Catalent Recent Developments
9.8 Siegfried
9.8.1 Siegfried Active Pharmaceutical Ingredients CDMO Basic Information
9.8.2 Siegfried Active Pharmaceutical Ingredients CDMO Product Overview
9.8.3 Siegfried Active Pharmaceutical Ingredients CDMO Product Market Performance
9.8.4 Siegfried Business Overview
9.8.5 Siegfried Recent Developments
9.9 Piramal Pharma Solutions
9.9.1 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Basic Information
9.9.2 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Overview
9.9.3 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Market Performance
9.9.4 Piramal Pharma Solutions Business Overview
9.9.5 Piramal Pharma Solutions Recent Developments
9.10 Boehringer Ingelheim
9.10.1 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Basic Information
9.10.2 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Overview
9.10.3 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Market Performance
9.10.4 Boehringer Ingelheim Business Overview
9.10.5 Boehringer Ingelheim Recent Developments
10 ACTIVE PHARMACEUTICAL INGREDIENTS CDMO MARKET FORECAST BY REGION
10.1 Global Active Pharmaceutical Ingredients CDMO Market Size Forecast
10.2 Global Active Pharmaceutical Ingredients CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Active Pharmaceutical Ingredients CDMO Market Size Forecast by Region
10.2.4 South America Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Active Pharmaceutical Ingredients CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Active Pharmaceutical Ingredients CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Active Pharmaceutical Ingredients CDMO by Type (2025-2030)
11.1.2 Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Active Pharmaceutical Ingredients CDMO by Type (2025-2030)
11.2 Global Active Pharmaceutical Ingredients CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Active Pharmaceutical Ingredients CDMO Sales (K Units) Forecast by Application
11.2.2 Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Active Pharmaceutical Ingredients CDMO Market Size Comparison by Region (M USD)
Table 5. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Active Pharmaceutical Ingredients CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients CDMO as of 2022)
Table 10. Global Market Active Pharmaceutical Ingredients CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Active Pharmaceutical Ingredients CDMO Sales Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredients CDMO Product Type
Table 13. Global Active Pharmaceutical Ingredients CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Active Pharmaceutical Ingredients CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Active Pharmaceutical Ingredients CDMO Market Challenges
Table 22. Global Active Pharmaceutical Ingredients CDMO Sales by Type (K Units)
Table 23. Global Active Pharmaceutical Ingredients CDMO Market Size by Type (M USD)
Table 24. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Active Pharmaceutical Ingredients CDMO Market Size Share by Type (2019-2024)
Table 28. Global Active Pharmaceutical Ingredients CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) by Application
Table 30. Global Active Pharmaceutical Ingredients CDMO Market Size by Application
Table 31. Global Active Pharmaceutical Ingredients CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Active Pharmaceutical Ingredients CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Active Pharmaceutical Ingredients CDMO Market Share by Application (2019-2024)
Table 35. Global Active Pharmaceutical Ingredients CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Active Pharmaceutical Ingredients CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Active Pharmaceutical Ingredients CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Active Pharmaceutical Ingredients CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Active Pharmaceutical Ingredients CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Cambrex Active Pharmaceutical Ingredients CDMO Basic Information
Table 44. Cambrex Active Pharmaceutical Ingredients CDMO Product Overview
Table 45. Cambrex Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Cambrex Business Overview
Table 47. Cambrex Active Pharmaceutical Ingredients CDMO SWOT Analysis
Table 48. Cambrex Recent Developments
Table 49. Recipharm Active Pharmaceutical Ingredients CDMO Basic Information
Table 50. Recipharm Active Pharmaceutical Ingredients CDMO Product Overview
Table 51. Recipharm Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Recipharm Business Overview
Table 53. Recipharm Active Pharmaceutical Ingredients CDMO SWOT Analysis
Table 54. Recipharm Recent Developments
Table 55. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Basic Information
Table 56. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Overview
Table 57. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO SWOT Analysis
Table 59. Thermo Fisher Pantheon Business Overview
Table 60. Thermo Fisher Pantheon Recent Developments
Table 61. Corden Pharma Active Pharmaceutical Ingredients CDMO Basic Information
Table 62. Corden Pharma Active Pharmaceutical Ingredients CDMO Product Overview
Table 63. Corden Pharma Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Corden Pharma Business Overview
Table 65. Corden Pharma Recent Developments
Table 66. Samsung Biologics Active Pharmaceutical Ingredients CDMO Basic Information
Table 67. Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Overview
Table 68. Samsung Biologics Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Samsung Biologics Business Overview
Table 70. Samsung Biologics Recent Developments
Table 71. Lonza Active Pharmaceutical Ingredients CDMO Basic Information
Table 72. Lonza Active Pharmaceutical Ingredients CDMO Product Overview
Table 73. Lonza Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lonza Business Overview
Table 75. Lonza Recent Developments
Table 76. Catalent Active Pharmaceutical Ingredients CDMO Basic Information
Table 77. Catalent Active Pharmaceutical Ingredients CDMO Product Overview
Table 78. Catalent Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Catalent Business Overview
Table 80. Catalent Recent Developments
Table 81. Siegfried Active Pharmaceutical Ingredients CDMO Basic Information
Table 82. Siegfried Active Pharmaceutical Ingredients CDMO Product Overview
Table 83. Siegfried Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Siegfried Business Overview
Table 85. Siegfried Recent Developments
Table 86. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Basic Information
Table 87. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Overview
Table 88. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Piramal Pharma Solutions Business Overview
Table 90. Piramal Pharma Solutions Recent Developments
Table 91. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Basic Information
Table 92. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Overview
Table 93. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Boehringer Ingelheim Business Overview
Table 95. Boehringer Ingelheim Recent Developments
Table 96. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Active Pharmaceutical Ingredients CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Active Pharmaceutical Ingredients CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Active Pharmaceutical Ingredients CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Active Pharmaceutical Ingredients CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Active Pharmaceutical Ingredients CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Active Pharmaceutical Ingredients CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Active Pharmaceutical Ingredients CDMO Market Size Comparison by Region (M USD)
Table 5. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Active Pharmaceutical Ingredients CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Active Pharmaceutical Ingredients CDMO as of 2022)
Table 10. Global Market Active Pharmaceutical Ingredients CDMO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Active Pharmaceutical Ingredients CDMO Sales Sites and Area Served
Table 12. Manufacturers Active Pharmaceutical Ingredients CDMO Product Type
Table 13. Global Active Pharmaceutical Ingredients CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Active Pharmaceutical Ingredients CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Active Pharmaceutical Ingredients CDMO Market Challenges
Table 22. Global Active Pharmaceutical Ingredients CDMO Sales by Type (K Units)
Table 23. Global Active Pharmaceutical Ingredients CDMO Market Size by Type (M USD)
Table 24. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) by Type (2019-2024)
Table 25. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Active Pharmaceutical Ingredients CDMO Market Size Share by Type (2019-2024)
Table 28. Global Active Pharmaceutical Ingredients CDMO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) by Application
Table 30. Global Active Pharmaceutical Ingredients CDMO Market Size by Application
Table 31. Global Active Pharmaceutical Ingredients CDMO Sales by Application (2019-2024) & (K Units)
Table 32. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Active Pharmaceutical Ingredients CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Active Pharmaceutical Ingredients CDMO Market Share by Application (2019-2024)
Table 35. Global Active Pharmaceutical Ingredients CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Active Pharmaceutical Ingredients CDMO Sales by Region (2019-2024) & (K Units)
Table 37. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Active Pharmaceutical Ingredients CDMO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Active Pharmaceutical Ingredients CDMO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales by Region (2019-2024) & (K Units)
Table 41. South America Active Pharmaceutical Ingredients CDMO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales by Region (2019-2024) & (K Units)
Table 43. Cambrex Active Pharmaceutical Ingredients CDMO Basic Information
Table 44. Cambrex Active Pharmaceutical Ingredients CDMO Product Overview
Table 45. Cambrex Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Cambrex Business Overview
Table 47. Cambrex Active Pharmaceutical Ingredients CDMO SWOT Analysis
Table 48. Cambrex Recent Developments
Table 49. Recipharm Active Pharmaceutical Ingredients CDMO Basic Information
Table 50. Recipharm Active Pharmaceutical Ingredients CDMO Product Overview
Table 51. Recipharm Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Recipharm Business Overview
Table 53. Recipharm Active Pharmaceutical Ingredients CDMO SWOT Analysis
Table 54. Recipharm Recent Developments
Table 55. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Basic Information
Table 56. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product Overview
Table 57. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO SWOT Analysis
Table 59. Thermo Fisher Pantheon Business Overview
Table 60. Thermo Fisher Pantheon Recent Developments
Table 61. Corden Pharma Active Pharmaceutical Ingredients CDMO Basic Information
Table 62. Corden Pharma Active Pharmaceutical Ingredients CDMO Product Overview
Table 63. Corden Pharma Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Corden Pharma Business Overview
Table 65. Corden Pharma Recent Developments
Table 66. Samsung Biologics Active Pharmaceutical Ingredients CDMO Basic Information
Table 67. Samsung Biologics Active Pharmaceutical Ingredients CDMO Product Overview
Table 68. Samsung Biologics Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Samsung Biologics Business Overview
Table 70. Samsung Biologics Recent Developments
Table 71. Lonza Active Pharmaceutical Ingredients CDMO Basic Information
Table 72. Lonza Active Pharmaceutical Ingredients CDMO Product Overview
Table 73. Lonza Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Lonza Business Overview
Table 75. Lonza Recent Developments
Table 76. Catalent Active Pharmaceutical Ingredients CDMO Basic Information
Table 77. Catalent Active Pharmaceutical Ingredients CDMO Product Overview
Table 78. Catalent Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Catalent Business Overview
Table 80. Catalent Recent Developments
Table 81. Siegfried Active Pharmaceutical Ingredients CDMO Basic Information
Table 82. Siegfried Active Pharmaceutical Ingredients CDMO Product Overview
Table 83. Siegfried Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Siegfried Business Overview
Table 85. Siegfried Recent Developments
Table 86. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Basic Information
Table 87. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product Overview
Table 88. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Piramal Pharma Solutions Business Overview
Table 90. Piramal Pharma Solutions Recent Developments
Table 91. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Basic Information
Table 92. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product Overview
Table 93. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Boehringer Ingelheim Business Overview
Table 95. Boehringer Ingelheim Recent Developments
Table 96. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Active Pharmaceutical Ingredients CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Active Pharmaceutical Ingredients CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Active Pharmaceutical Ingredients CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Active Pharmaceutical Ingredients CDMO Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Active Pharmaceutical Ingredients CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Active Pharmaceutical Ingredients CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Active Pharmaceutical Ingredients CDMO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Active Pharmaceutical Ingredients CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Active Pharmaceutical Ingredients CDMO Market Size (M USD), 2019-2030
Figure 5. Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Active Pharmaceutical Ingredients CDMO Market Size by Country (M USD)
Figure 11. Active Pharmaceutical Ingredients CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Manufacturers in 2023
Figure 13. Active Pharmaceutical Ingredients CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Active Pharmaceutical Ingredients CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Active Pharmaceutical Ingredients CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Active Pharmaceutical Ingredients CDMO Market Share by Type
Figure 18. Sales Market Share of Active Pharmaceutical Ingredients CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Active Pharmaceutical Ingredients CDMO by Type in 2023
Figure 20. Market Size Share of Active Pharmaceutical Ingredients CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Active Pharmaceutical Ingredients CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Active Pharmaceutical Ingredients CDMO Market Share by Application
Figure 24. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Application in 2023
Figure 26. Global Active Pharmaceutical Ingredients CDMO Market Share by Application (2019-2024)
Figure 27. Global Active Pharmaceutical Ingredients CDMO Market Share by Application in 2023
Figure 28. Global Active Pharmaceutical Ingredients CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Active Pharmaceutical Ingredients CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Active Pharmaceutical Ingredients CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Active Pharmaceutical Ingredients CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Active Pharmaceutical Ingredients CDMO Sales Market Share by Country in 2023
Figure 37. Germany Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales Market Share by Region in 2023
Figure 44. China Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (K Units)
Figure 50. South America Active Pharmaceutical Ingredients CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Active Pharmaceutical Ingredients CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Active Pharmaceutical Ingredients CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Active Pharmaceutical Ingredients CDMO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Active Pharmaceutical Ingredients CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Active Pharmaceutical Ingredients CDMO Market Size (M USD), 2019-2030
Figure 5. Global Active Pharmaceutical Ingredients CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Active Pharmaceutical Ingredients CDMO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Active Pharmaceutical Ingredients CDMO Market Size by Country (M USD)
Figure 11. Active Pharmaceutical Ingredients CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Manufacturers in 2023
Figure 13. Active Pharmaceutical Ingredients CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Active Pharmaceutical Ingredients CDMO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Active Pharmaceutical Ingredients CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Active Pharmaceutical Ingredients CDMO Market Share by Type
Figure 18. Sales Market Share of Active Pharmaceutical Ingredients CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Active Pharmaceutical Ingredients CDMO by Type in 2023
Figure 20. Market Size Share of Active Pharmaceutical Ingredients CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Active Pharmaceutical Ingredients CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Active Pharmaceutical Ingredients CDMO Market Share by Application
Figure 24. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Application in 2023
Figure 26. Global Active Pharmaceutical Ingredients CDMO Market Share by Application (2019-2024)
Figure 27. Global Active Pharmaceutical Ingredients CDMO Market Share by Application in 2023
Figure 28. Global Active Pharmaceutical Ingredients CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Active Pharmaceutical Ingredients CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Active Pharmaceutical Ingredients CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Active Pharmaceutical Ingredients CDMO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Active Pharmaceutical Ingredients CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Active Pharmaceutical Ingredients CDMO Sales Market Share by Country in 2023
Figure 37. Germany Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Active Pharmaceutical Ingredients CDMO Sales Market Share by Region in 2023
Figure 44. China Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (K Units)
Figure 50. South America Active Pharmaceutical Ingredients CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Active Pharmaceutical Ingredients CDMO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Active Pharmaceutical Ingredients CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Active Pharmaceutical Ingredients CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Active Pharmaceutical Ingredients CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Active Pharmaceutical Ingredients CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Active Pharmaceutical Ingredients CDMO Market Share Forecast by Application (2025-2030)
